Historical record - last NADAC effective date: 5/20/2015
Product Information
VENLAFAXINE HCL 50 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3260 per EA under NDC 65862040601. Its NADAC has been published 78 times since Nov 28, 2013.
FDA first approved this application on Apr 7, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862040601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2015
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090555FDA Approved
4/7/2010
TE Code
AB
On Market Since
4/7/2010
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 50 MG TABLET has been published 78 times since Nov 28, 2013, and over the history we have for it it has declined 11.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3260 per EA |
|---|---|
| All-time high | $0.4798 (Feb 12, 2014) |
| All-time low | $0.3233 (Oct 22, 2014) |
| Median price | $0.3677 |
| Average price | $0.3742 |
| Largest weekly change | +30.5% (Jan 22, 2014) |
| Weeks tracked | 78 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-11.5%
Last surveyed May 20, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 68% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 50 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.3260 per EA (NDC 65862040601), effective May 20, 2015.
How has the price of VENLAFAXINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 50 MG TABLET has declined 11.5%. It has been tracked across 78 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 50 MG TABLET?
Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL 50 MG TABLET has ranged from a low of $0.3233 (Oct 22, 2014) to a high of $0.4798 (Feb 12, 2014), with a median of $0.3677 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 50 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VENLAFAXINE HCL 50 MG TABLET, is $0.1047 per EA — about 68% below VENLAFAXINE HCL 50 MG TABLET.
Who manufactures VENLAFAXINE HCL 50 MG TABLET?
VENLAFAXINE HCL 50 MG TABLET (NDC 65862040601) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.